BioSpace News Archive

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for pralsetinib for the treatment of patients with advanced or metast

Tektronix has shifted its work from supporting vehicle manufacturing to assisting with ventilator production

- On-Track for September Launch of Phexxi™, the First FDA-Approved, Non-Hormonal, On-Demand Prescription Contraceptive Gel - - Advancing EVO100 for the Prevention of Urogenital Chlamydia and Gonorrhea - - ~ $136 Million Gross Proceeds Raised; Funding Expected to Carry the Company into Q2 2021 -

Crestone, Inc. today announced a contract award from the National Institutes of Health for the advancement of its antibiotic candidate CRS0540 to treat infections caused by drug-resistant Gram-positive bacteria. The lead compound CRS0540 has demonstrated efficacy in several mouse models of infection including MRSA soft tissue and blood stream infections, pneumococcal lung infection, and even an inhalational anthrax ch

PanTheryx, the world’s largest colostrum-based nutrition and biotechnology company, announced today the appointment of Tom Feeley to the position of Chief Financial Officer (CFO). Mr. Feeley began his role with PanTheryx on June 22 and reports to President and Chief Executive Officer Wes Parris. Mr. Feeley will be responsible for the development and execution of PanTheryx’s financial strategy including all Finance, Account

Dow (NYSE: DOW) today announced its MobilityScience™ platform designed to enhance the customer experience by tailoring technologies, products, and services from across Dow businesses to the transportation industry.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient with triple negative breas

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Elizabeth Tallett has joined its Board of Directors. Ms. Tallett was also appointed to serve on the Audit Committee of the Board. With

Quantabio , a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced that its UltraPlex 1-Step ToughMix was recognized as part of the expanded emergency use authorization (EUA)

Sharps Compliance Corp., a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, announced the appointment of Adrian W. Burke as Senior Vice President of Operations.